Ann: Positive Results from the SOLVE-CRT Randomised Sub-Study, page-10

Honestly, there's times when I'm glad the market is irrational. I've just put a bit of capital into a couple other stocks- I'm not a wealthy man, and have to space my buys and choose carefully with my limited income. I'd judged that there wasn't too much of a hurry here- and I'd have been annoyed if this took off while my mind and funds were focused elsewhere. To still be able to buy in the .80 - .90 range suits just fine.

Can I ask a rookie question of the veterans among us; can you judge how 'known' a stock is by any measurable metric? By the volume traded, or spread of different buyers for example? Is there any real way of seeing how aware the market is of a stock?

I only ask because I'm a bit stunned that we're still sitting here sub 1.00, when a) FDA approval seems a given, b) this is a product many people need, and c) we essentially have a monopoly on that product... Is it that EBR is still unknown by the wider market- or do the instos judge they have time to deploy capital elsewhere in the period between now and approval? Or (and perhaps this is the more obvious explanation) am I just over estimating the likelihood of EBR returning multiples?

Any thoughts appreciated.